These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 39327253

  • 21. METTL3-mediated m6A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy.
    Cheng X, Yang H, Chen Y, Zeng Z, Liu Y, Zhou X, Zhang C, Xie A, Wang G.
    Cell Mol Biol Lett; 2024 Aug 14; 29(1):109. PubMed ID: 39143552
    [Abstract] [Full Text] [Related]

  • 22. METTL3-mediated m6A methylation of SLC38A1 stimulates cervical cancer growth.
    Liu HT, Zhao Y, Wang HC, Liu QL.
    Biochem Biophys Res Commun; 2024 Apr 30; 716():150039. PubMed ID: 38701556
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. RNA m6 A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c-Met.
    Luo G, Xu W, Zhao Y, Jin S, Wang S, Liu Q, Chen X, Wang J, Dong F, Hu DN, Reinach PS, Yan D.
    J Cell Physiol; 2020 Oct 30; 235(10):7107-7119. PubMed ID: 32017066
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.
    Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, Chen J, Cheng M, Huang Z, Ren H, Chen J, Peng L, Gao F, Chen D, Wang A.
    Mol Ther; 2020 Oct 07; 28(10):2177-2190. PubMed ID: 32621798
    [Abstract] [Full Text] [Related]

  • 28. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.
    Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, Chen ZH, Zeng ZL, Wang F, Zheng J, Chen D, Li B, Kang TB, Xie D, Lin D, Ju HQ, Xu RH.
    Mol Cancer; 2019 Jun 24; 18(1):112. PubMed ID: 31230592
    [Abstract] [Full Text] [Related]

  • 29. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
    Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J, Chen P, Xiang Z, Rao Q, Han X.
    Theranostics; 2021 Jun 24; 11(16):7640-7657. PubMed ID: 34335955
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
    Zhang Y, Liu S, Zhao T, Dang C.
    Oncol Rep; 2021 Aug 24; 46(2):. PubMed ID: 34132367
    [Abstract] [Full Text] [Related]

  • 32. METTL3-m6A methylation inhibits the proliferation and viability of type II alveolar epithelial cells in acute lung injury by enhancing the stability and translation efficiency of Pten mRNA.
    Wang Q, Shen J, Luo S, Yuan Z, Wei S, Li Q, Yang Q, Luo Y, Zhuang L.
    Respir Res; 2024 Jul 15; 25(1):276. PubMed ID: 39010105
    [Abstract] [Full Text] [Related]

  • 33. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].
    Zhang Y, Wang Y, Liu M.
    Zhongguo Fei Ai Za Zhi; 2024 Jan 02; 26(12):919-933. PubMed ID: 38163978
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X, Zhang Z, Wang L, Zhang S, Ren L, Li S, Xu J, Lv S.
    Bioengineered; 2021 Dec 02; 12(2):10023-10036. PubMed ID: 34666602
    [Abstract] [Full Text] [Related]

  • 35. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.
    Wu H, Li F, Zhu R.
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar 02; 53(3):304-316. PubMed ID: 33355622
    [Abstract] [Full Text] [Related]

  • 36. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J, Xie H, Ying Y, Chen H, Yan H, He L, Xu M, Xu X, Liang Z, Liu B, Wang X, Zheng X, Xie L.
    Mol Cancer; 2020 Oct 29; 19(1):152. PubMed ID: 33121495
    [Abstract] [Full Text] [Related]

  • 37. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
    Zhang F, Yan Y, Cao X, Zhang J, Li Y, Guo C.
    Aging (Albany NY); 2021 Apr 21; 13(8):12224-12238. PubMed ID: 33882457
    [Abstract] [Full Text] [Related]

  • 38. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, Wei JF, Yang H.
    Mol Cancer; 2019 Jun 22; 18(1):110. PubMed ID: 31228940
    [Abstract] [Full Text] [Related]

  • 39. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Gong Y, Luo G, Zhang S, Chen Y, Hu Y.
    Cell Signal; 2024 May 22; 117():111068. PubMed ID: 38286198
    [Abstract] [Full Text] [Related]

  • 40. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.
    Xu Y, Bao Y, Qiu G, Ye H, He M, Wei X.
    Mol Med Rep; 2023 Nov 22; 28(5):. PubMed ID: 37772373
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.